CTL1 (SLC44A1) regulates myelin lipid composition and architecture in Schwann cells

Myelin formation requires extensive membrane lipid synthesis, yet how myelinating glia acquire the choline needed for this process remains incompletely understood. Choline transporter-like protein 1 (CTL1; SLC44A1) is highly expressed in Schwann cells, and CTL1 deficiency in oligodendrocytes impairs CNS myelination. Here, we examined the role of CTL1 in peripheral nerve myelination using Schwann cell-specific Ctl1 knockout mice. Unexpectedly, loss of Ctl1 did not alter Schwann cell differentiation, the number of myelinated axons, or myelin thickness, but increased myelin abnormalities, including in-foldings and out-foldings. Lipidomic analysis revealed selective alterations in myelin lipid composition, particularly among long-chain lipid species, together with triglyceride accumulation in whole nerves. CTL1 deficiency also increased mTORC1-associated S6 and mTORC2-associated AKT S473 phosphorylation. Transcriptomic analysis revealed downregulation of gene programs associated with fatty acid {beta}-oxidation, triglyceride catabolism, and oxidative phosphorylation. Following peripheral nerve injury, Ctl1-deficient Schwann cells generated a normal repair response and efficiently remyelinated regenerated axons despite altered mTOR signaling. Together, these findings demonstrate that CTL1 is not required for overall peripheral myelin production but contributes to maintaining normal myelin lipid composition and architecture, revealing an unexpected ability of Schwann cells to sustain myelination despite disruption of CTL1-dependent choline metabolism